A guide for measurement of circulating metabolic hormones in rodents: Pitfalls during the pre-analytical phase

Molecular Metabolism

Volumn 1, Issue 1-2, 2012, Pages 47-60

  Bielohuby, Maximilian ^a   Popp, Sarah ^a   Bidlingmaier, Martin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hormone measurement; Immunoassay; Mouse; Pre analytical variability; Rat; Sample processing

Indexed keywords

ANTICOAGULANT AGENT; BIOLOGICAL MARKER; CIRCULATING METABOLIC HORMONE; CITRIC ACID; EDETIC ACID; HEPARIN; HIRUDIN; HORMONE; UNCLASSIFIED DRUG;

ANALYTICAL ERROR; BLOOD CLOTTING; BLOOD SAMPLING; BLOOD STORAGE; CENTRIFUGATION; DILUTION; FEMALE; FREEZE THAWING; HEMOLYSIS; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; IMMUNOASSAY; LABORATORY DIAGNOSIS; MALE; METHODOLOGY; NONHUMAN; PLASMA; PRIORITY JOURNAL; QUALITY CONTROL PROCEDURES; RAT; RELIABILITY; SAMPLE SIZE; SERUM; SHORT SURVEY; TEMPERATURE;

RATTUS; RODENTIA;

EID: 84871865333     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2012.07.004     Document Type: Short Survey

References (65)

1. Becan-McBride K. Laboratory sampling. Does the process affect the outcome?. J Intraven Nurs 1999, 22:137-142.
2. Lippi G., Chance J.J., Church S., Dazzi P., Fontana R., Giavarina D., et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 2011, 49:1113-1126.
3. Plebani M. Errors in clinical laboratories or errors in laboratory medicine?. Clin Chem Lab Med 2006, 44:750-759.
4. Bonini P., Plebani M., Ceriotti F., Rubboli F. Errors in laboratory medicine. Clin Chem 2002, 48:691-698.
5. Banks R.E. Preanalytical influences in clinical proteomic studies: raising awareness of fundamental issues in sample banking. Clin Chem 2008, 54:6-7.
6. Palmer A.J., Chung M.Y., List E.O., Walker J., Okada S., Kopchick J.J., et al. Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 2009, 150:1353-1360.
7. Bielohuby M., Bidlingmaier M. Highlighting the importance of age and gender in obesity research. Obes Metab-Milan 2008, 4:221-223.
8. Catalano K.J., Bergman R.N., Ader M. Increased susceptibility to insulin resistance associated with abdominal obesity in aging rats. Obes Res 2005, 13:11-20.
9. Reed J.A., Benoit S.C., Pfluger P.T., Tschop M.H., D'Alessio D.A., Seeley R.J. Mice with chronically increased circulating ghrelin develop age-related glucose intolerance. Am J Physiol Endocrinol Metab 2008, 294:E752-760.
10. Bielohuby M., Schaab M., Kummann M., Sawitzky M., Gebhardt R., Binder G., et al. Serum IGF-I is not a reliable pharmacodynamic marker of exogenous growth hormone activity in mice. Endocrinology 2011, 152:4764-4776.
11. Sonntag O. Analytical interferences and analytical quality. Clin Chim Acta 2009, 404:37-40.
12. Laron Z., Bidlingmaier M., Strasburger C.J. Indications, limitations and pitfalls in the determination of human growth hormone, IGF-I and their binding proteins. Pediatr Endocrinol Rev 2007, 5(Suppl. 1):555-569.
13. Strasburger C.J., Bidlingmaier M. How robust are laboratory measures of growth hormone status?. Horm Res 2005, 64(Suppl. 2):1-5.
14. Petersen P.H., Ricos C., Stockl D., Libeer J.C., Baadenhuijsen H., Fraser C., et al. Proposed guidelines for the internal quality control of analytical results in the medical laboratory. Eur J Clin Chem Clin Biochem 1996, 34:983-999.
15. Tammen H. Specimen collection and handling: standardization of blood sample collection. Methods Mol Biol 2008, 428:35-42.
16. Wojcik M., Stec W.J. The effect of divalent cations on the catalytic activity of the human plasma 3'-exonuclease. Biometals 2010, 23:1113-1121.
17. Jung K. Consideration of preanalytical conditions to use circulating matrix metalloproteinases as diagnostic markers. Transplantation 2005, 79:744.
18. Verspaget H.W., Kuyvenhoven J.P., van Hoek B. Preanalytical conditions and circulating matrix metalloproteinases. Transplantation 2005, 79:745-746.
19. Meakin J.W., Tingey W.H., Nelson D.H. The catabolism of adrenocorticotropic hormone: the stability of adrenocorticotropic hormone: the stability of adrenocorticotropic hormone in blood, plasma, serum, and saline. Endocrinology 1960, 66:59-72.
20. Reisch N., Reincke M., Bidlingmaier M. Preanalytical stability of adrenocorticotropic hormone depends on time to centrifugation rather than temperature. Clin Chem 2007, 53:358-359.
21. Campbell D.J., Nussberger J., Stowasser M., Danser A.H., Morganti A., Frandsen E., et al. Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 2009, 55:867-877.
22. Locsei Z., Racz K., Patocs A., Kovacs G.L., Toldy E. Influence of sampling and storage conditions on plasma renin activity and plasma renin concentration. Clin Chim Acta 2009, 402:203-205.
23. Jane Ellis M., Livesey J.H., Evans M.J. Hormone stability in human whole blood. Clin Biochem 2003, 36:109-112.
24. Schneider S., Brummer V., Carnahan H., Dubrowski A., Askew C.D., Struder H.K. Stress hormone stability: processing of blood samples collected during parabolic flight. A pre-flight comparison of different protocols. Clin Biochem 2007, 40:1332-1335.
25. Livesey J.H., Ellis M.J., Evans M.J. Pre-analytical requirements. Clin Biochem Rev 2008, 29(Suppl. 1):S11-15.
26. Reimers T.J., McCann J.P., Cowan R.G. Effects of storage times and temperatures on T3, T4, LH, prolactin, insulin, cortisol and progesterone concentrations in blood samples from cows. J Anim Sci 1983, 57:683-691.
27. Lombardi G., Lanteri P., Colombini A., Banfi G. Blood biochemical markers of bone turnover: pre-analytical and technical aspects of sample collection and handling. Clin Chem Lab Med 2012, 50:771-789.
28. Schrohl A.S., Wurtz S., Kohn E., Banks R.E., Nielsen H.J., Sweep F.C., et al. Banking of biological fluids for studies of disease-associated protein biomarkers. Mol Cell Proteomics 2008, 7:2061-2066.
29. Bowen R.A., Hortin G.L., Csako G., Otanez O.H., Remaley A.T. Impact of blood collection devices on clinical chemistry assays. Clin Biochem 2010, 43:4-25.
30. Lippi G., Franchini M., Montagnana M., Salvagno G.L., Poli G., Guidi G.C. Quality and reliability of routine coagulation testing: can we trust that sample?. Blood Coagul Fibrinolysis 2006, 17:513-519.
31. Kontny N.E., Hempel G., Boos J., Boddy A.V., Krischke M. Minimization of the preanalytical error in plasma samples for pharmacokinetic analyses and therapeutic drug monitoring-using doxorubicin as an example. Ther Drug Monit 2011, 33:766-771.
32. Lippi G., Salvagno G.L., Montagnana M., Brocco G., Guidi G.C. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med 2006, 44:311-316.
33. Koseoglu M., Hur A., Atay A., Cuhadar S. Effects of hemolysis interferences on routine biochemistry parameters. Biochem Med (Zagreb) 2011, 21:79-85.
34. Bellomo G., Sulas M.G., Mairate E., Bardone M.B., Rolla R. Hemolysis is a major cause of variability in insulin measurement during oral glucose tolerance test in children. Clin Lab 2012, 58:67-74.
35. Arola L., Palou A., Remesar X., Herrera E., Alemany M. Effect of stress and sampling site on metabolite concentration in rat plasma. Arch Int Physiol Biochim 1980, 88:99-105.
36. Fitzner Toft M., Petersen M.H., Dragsted N., Hansen A.K. The impact of different blood sampling methods on laboratory rats under different types of anaesthesia. Lab Anim 2006, 40:261-274.
37. Aasland K.E., Skjerve E., Smith A.J. Quality of blood samples from the saphenous vein compared with the tail vein during multiple blood sampling of mice. Lab Anim 2010, 44:25-29.
38. Christensen S.D., Mikkelsen L.F., Fels J.J., Bodvarsdottir T.B., Hansen A.K. Quality of plasma sampled by different methods for multiple blood sampling in mice. Lab Anim 2009, 43:65-71.
39. Vahl T.P., Ulrich-Lai Y.M., Ostrander M.M., Dolgas C.M., Elfers E.E., Seeley R.J., et al. Comparative analysis of ACTH and corticosterone sampling methods in rats. Am J Physiol Endocrinol Metab 2005, 289:E823-828.
40. Evans M.J., Livesey J.H., Ellis M.J., Yandle T.G. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin Biochem 2001, 34:107-112.
41. Vogeser M., Parhofer K.G. Limited preanalytical requirements for insulin measurement. Clin Biochem 2005, 38:572-575.
42. O'Keane M.P., Cunningham S.K. Evaluation of three different specimen types (serum, plasma lithium heparin and serum gel separator) for analysis of certain analytes: clinical significance of differences in results and efficiency in use. Clin Chem Lab Med 2006, 44:662-668.
43. Heijboer A.C., Frans A., Lomecky M., Blankenstein M.A. Analysis of glucagon-like peptide 1: what to measure?. Clin Chim Acta 2011, 412:1191-1194.
44. Thornberry N.A., Gallwitz B. Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4). Best Pract Res Clin Endocrinol Metab 2009, 23:479-486.
45. Prudom C., Liu J., Patrie J., Gaylinn B.D., Foster-Schubert K.E., Cummings D.E., et al. Comparison of competitive radioimmunoassays and two-site sandwich assays for the measurement and interpretation of plasma ghrelin levels. J Clin Endocrinol Metab 2010, 95:2351-2358.
46. Stengel A., Keire D., Goebel M., Evilevitch L., Wiggins B., Tache Y., et al. The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology 2009, 150:5113-5118.
47. Lippi G., Montagnana M., Giavarina D. National survey on the pre-analytical variability in a representative cohort of Italian laboratories. Clin Chem Lab Med 2006, 44:1491-1494.
48. Watt A.D., Perez K.A., Rembach A.R., Masters C.L., Villemagne V.L., Barnham K.J. Variability in blood-based amyloid-beta assays: the need for consensus on pre-analytical processing. J Alzheimers Dis 2012, 30:323-336.
49. Vanderstichele H., Bibl M., Engelborghs S., Le Bastard N., Lewczuk P., Molinuevo J.L., et al. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimers Dement 2012, 8:65-73.
50. Alsina M.J., Alvarez V., Barba N., Bullich S., Cortes M., Escoda I., et al. Preanalytical quality control program-an overview of results (2001-2005 summary). Clin Chem Lab Med 2008, 46:849-854.
51. Wallin O., Soderberg J., Van Guelpen B., Stenlund H., Grankvist K., Brulin C. Blood sample collection and patient identification demand improvement: a questionnaire study of preanalytical practices in hospital wards and laboratories. Scand J Caring Sci 2010, 24:581-591.
52. Simundic A.M., Nikolac N., Vukasovic I., Vrkic N. The prevalence of preanalytical errors in a Croatian ISO 15189 accredited laboratory. Clin Chem Lab Med 2010, 48:1009-1014.
53. Tuck M.K., Chan D.W., Chia D., Godwin A.K., Grizzle W.E., Krueger K.E., et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res 2009, 8:113-117.
54. Vacata V, Jahns-Streubel G, Baldus M, Wood WG Practical solution for control of the pre-analytical phase in decentralized clinical laboratories for meeting the requirements of the medical laboratory accreditation standard DIN EN ISO 15189. Clin Lab 2007, 53:211-215.
55. Diver M.J., Hughes J.G., Hutton J.L., West C.R., Hipkin L.J. The long-term stability in whole blood of 14 commonly-requested hormone analytes. Ann Clin Biochem 1994, 31(Part 6):561-565.
56. Bernini P., Bertini I., Luchinat C., Nincheri P., Staderini S., Turano P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR 2011, 49:231-243.
57. Zielhuis G.A. Biobanking for epidemiology. Public Health 2012, 126:214-216.
58. Tworoger S.S., Hankinson S.E. Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples. Cancer Epidemiol Biomarkers Prev 2006, 15:1578-1581.
59. Arnold M., Langhans W. Effects of anesthesia and blood sampling techniques on plasma metabolites and corticosterone in the rat. Physiol Behav 2010, 99:592-598.
60. Ceron J.J., Martinez-Subiela S., Hennemann C., Tecles F. The effects of different anticoagulants on routine canine plasma biochemistry. Vet J 2004, 167:294-301.
61. Olsen A.K., Bladbjerg E.M., Jensen A.L., Hansen A.K. Effect of pre-analytical handling on haematological variables in minipigs. Lab Anim 2001, 35:147-152.
62. Stokol T., Nydam D.V. Effect of anticoagulant and storage conditions on bovine nonesterified fatty acid and beta-hydroxybutyrate concentrations in blood. J Dairy Sci 2005, 88:3139-3144.
63. Mohri M., Rezapoor H. Effects of heparin, citrate, and EDTA on plasma biochemistry of sheep: comparison with serum. Res Vet Sci 2009, 86:111-114.
64. Holobaugh P.A., McChesney D.C. Effect of anticoagulants and heat on the detection of tumor necrosis factor in murine blood. J Immunol Methods 1990, 135:95-99.
65. Liu J., Prudom C.E., Nass R., Pezzoli S.S., Oliveri M.C., Johnson M.L., et al. Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J Clin Endocrinol Metab 2008, 93:1980-1987.